Stephan Gade
Stephan Gade
Cellzome, a GSK company
Verified email at
Cited by
Cited by
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2–positive and triple-negative …
C Denkert, G Von Minckwitz, JC Brase, BV Sinn, S Gade, R Kronenwett, ...
Journal of clinical oncology 33 (9), 983-991, 2015
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry
H Franken, T Mathieson, D Childs, GMA Sweetman, T Werner, I Tögel, ...
Nature protocols 10 (10), 1567-1593, 2015
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer
J Weischenfeldt, R Simon, L Feuerbach, K Schlangen, D Weichenhan, ...
Cancer cell 23 (2), 159-170, 2013
PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in …
S Loibl, G Von Minckwitz, A Schneeweiss, S Paepke, A Lehmann, ...
Journal of clinical oncology 32 (29), 3212-3220, 2014
Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis
MM Savitski, N Zinn, M Faelth-Savitski, D Poeckel, S Gade, I Becher, ...
Cell 173 (1), 260-274. e25, 2018
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
JC Brase, M Johannes, H Mannsperger, M Fälth, J Metzger, LA Kacprzyk, ...
BMC cancer 11, 1-8, 2011
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
R Kuner, M Fälth, NC Pressinotti, JC Brase, SB Puig, J Metzger, S Gade, ...
Journal of molecular medicine 91, 237-248, 2013
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the …
V Müller, S Gade, B Steinbach, S Loibl, G von Minckwitz, M Untch, ...
Breast cancer research and treatment 147, 61-68, 2014
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
C Fontanella, B Lederer, S Gade, M Vanoppen, JU Blohmer, SD Costa, ...
Breast cancer research and treatment 150, 127-139, 2015
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients
M Johannes, JC Brase, H Fröhlich, S Gade, M Gehrmann, M Fälth, ...
Bioinformatics 26 (17), 2136-2144, 2010
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
S Kaduthanam, S Gade, M Meister, JC Brase, M Johannes, H Dienemann, ...
Lung Cancer 80 (2), 223-227, 2013
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
JL Lindner, S Loibl, C Denkert, B Ataseven, PA Fasching, BM Pfitzner, ...
Annals of oncology 26 (1), 95-100, 2015
RPPanalyzer: Analysis of reverse-phase protein array data
HA Mannsperger, S Gade, F Henjes, T Beissbarth, U Korf
Bioinformatics 26 (17), 2202-2203, 2010
Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients
M Hilvo, S Gade, T Hyötyläinen, V Nekljudova, T Seppänen‐Laakso, ...
International Journal of Cancer 134 (7), 1725-1733, 2014
Monitoring cell-surface N-glycoproteome dynamics by quantitative proteomics reveals mechanistic insights into macrophage differentiation
M Kalxdorf, S Gade, HC Eberl, M Bantscheff
Molecular & Cellular Proteomics 16 (5), 770-785, 2017
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer
S Gade, C Porzelius, M Fälth, JC Brase, D Wuttig, R Kuner, H Binder, ...
BMC bioinformatics 12, 1-10, 2011
Joint Bayesian inference of condition-specific miRNA and transcription factor activities from combined gene and microRNA expression data
B Zacher, K Abnaof, S Gade, E Younesi, A Tresch, H Fröhlich
Bioinformatics 28 (13), 1714-1720, 2012
Abstract S1-06: Increased tumor-associated lymphocytes predict benefit from addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast …
C Denkert, S Loibl, C Salat, BV Sinn, C Schem, V Endris, P Klare, ...
Cancer Research 73 (24_Supplement), S1-06-S1-06, 2013
Abstract S3-1: Neoadjuvant Chemotherapy in the very young 35 years of age or younger
S Loibl, C Jackisch, S Gade, M Untch, S Paepke, S Kuemmel, ...
Cancer Research 72 (24_Supplement), S3-1-S3-1, 2012
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
JC Brase, H Mannsperger, H Fröhlich, S Gade, C Schmidt, S Wiemann, ...
Proteome science 8, 1-10, 2010
The system can't perform the operation now. Try again later.
Articles 1–20